UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy

Haematologica (Roma), 2024-01

2024

Volltextzugriff (PDF)

Copper deficiency anemia: review article

Annals of hematology, 2018-09, Vol.97 (9), p.1527-1534

2018

Volltextzugriff (PDF)

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma

Blood cancer journal (New York), 2021-01, Vol.11 (1), p.8-8, Article 8

2021

Volltextzugriff (PDF)

Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant

HemaSphere, 2023-04, Vol.7 (4), p.e869-n/a

2023

Volltextzugriff (PDF)

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement

JACC. Case reports, 2023-06, Vol.15, p.101840, Article 101840

2023

Volltextzugriff (PDF)

Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies

Cancer treatment reviews, 2020-08, Vol.88, p.102042-102042, Article 102042

2020

Volltextzugriff (PDF)

Anti‐CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study

American journal of hematology, 2024-09, Vol.99 (9), p.1712-1720

2024

Volltextzugriff (PDF)

Mantle Cell Lymphoma Presenting as Cholecystitis and Nephromegaly

Curēus (Palo Alto, CA), 2023-12

2023

Volltextzugriff (PDF)

Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Transplantation and cellular therapy, 2024-10, Vol.30 (10), p.1001-1001.e12

2024

Volltextzugriff (PDF)

Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience

Clinical lymphoma, myeloma and leukemia, 2022-05, Vol.22 (5), p.e300-e309

2022

Volltextzugriff (PDF)

Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma

Transplantation and cellular therapy, 2022-09, Vol.28 (9), p.610-617

2022

Volltextzugriff (PDF)

Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience

Clinical lymphoma, myeloma and leukemia, 2022-04, Vol.22 (4), p.e250-e260

2022

Volltextzugriff (PDF)

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Blood advances, 2022-09, Vol.6 (17), p.5210-5221

2022

Volltextzugriff (PDF)

Subcutaneous Mosunetuzumab Is Active and Has a Manageable Safety Profile in Patients with Previously Untreated, Low-Tumor Burden Follicular Lymphoma: Initial Results from the Phase II Morningsun Study

Blood, 2023-11, Vol.142 (Supplement 1), p.3029-3029

2023

Volltextzugriff (PDF)

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

Blood, 2023-11, Vol.142 (Supplement 1), p.4475-4475

2023

Volltextzugriff (PDF)

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Blood, 2023-11, Vol.142 (Supplement 1), p.2216-2216

2023

Volltextzugriff (PDF)

Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study

Blood, 2023-11, Vol.142 (Supplement 1), p.311-311

2023

Volltextzugriff (PDF)

Mogamulizumab-Associated Rash (MAR) Correlates with Longer Progression Free Survival in Cutaneous T Cell Lymphoma (CTCL)

Blood, 2022-11, Vol.140 (Supplement 1), p.1488-1490

2022

Volltextzugriff (PDF)

Eltrombopag Stimulation for Neutrophil and Platelet Recovery Following Axicabtagene Ciloleucel (axi-cel) Therapy in Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.12757-12759

2022

Volltextzugriff (PDF)

B- Cell Maturation Antigen (BCMA) Re-Emergence and Relapse Patterns Post-BCMA-Chimeric Antigen Receptor T Cell (CAR-T ) Therapy for Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.12781-12783

2022

Volltextzugriff (PDF)

Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.7006-7006

2024

Volltextzugriff (PDF)

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

Journal of clinical oncology, 2023-12, Vol.41 (35), p.5376-5387

2023

Volltextzugriff (PDF)

Comparison of Efficacy and Safety Profile of Allogeneic Versus Autologous CD19 Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies: A Systematic Review and Meta-Analysis

Blood, 2021-11, Vol.138 (Supplement 1), p.4824-4824

2021

Volltextzugriff (PDF)

Impact of Novel Agents on the Outcomes of Patients with Classic Hodgkin Lymphoma That Relapsed after Autologous Stem Cell Transplant

Blood, 2021-11, Vol.138 (Supplement 1), p.1373-1373

2021

Volltextzugriff (PDF)

1 – 25 von 209

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(157)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy

Copper deficiency anemia: review article

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma

Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement

Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies

Anti‐CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study

Mantle Cell Lymphoma Presenting as Cholecystitis and Nephromegaly

Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience

Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma

Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Subcutaneous Mosunetuzumab Is Active and Has a Manageable Safety Profile in Patients with Previously Untreated, Low-Tumor Burden Follicular Lymphoma: Initial Results from the Phase II Morningsun Study

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study

Mogamulizumab-Associated Rash (MAR) Correlates with Longer Progression Free Survival in Cutaneous T Cell Lymphoma (CTCL)

Eltrombopag Stimulation for Neutrophil and Platelet Recovery Following Axicabtagene Ciloleucel (axi-cel) Therapy in Lymphoma

B- Cell Maturation Antigen (BCMA) Re-Emergence and Relapse Patterns Post-BCMA-Chimeric Antigen Receptor T Cell (CAR-T ) Therapy for Multiple Myeloma

Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

Comparison of Efficacy and Safety Profile of Allogeneic Versus Autologous CD19 Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies: A Systematic Review and Meta-Analysis

Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy

Impact of Novel Agents on the Outcomes of Patients with Classic Hodgkin Lymphoma That Relapsed after Autologous Stem Cell Transplant

Suchergebnisse filtern